Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Seres Therapeutics Inc
Swot
Seres Therapeutics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Seres Therapeutics Inc has 14 Strengths, 8 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(14)
Weakness
(8)
Opportunity
(5)
Threats
(0)
Others
(1)
MACD Crossover Above Signal Line
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
MACD crossed above signal line previous end of day
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Annual Net Profits improving for last 2 years
Top Gainers
Volume Shockers
Highest Recovery from 52 Week Low
Stocks with Quarter Change % less than Industry
PE higher than Industry PE
Companies with High Debt
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
RSI indicating price weakness
Stocks Underperforming their Industry Price Change in the Quarter
Companies with Upcoming Results
Mutual Funds Increased Shareholding in Past Month
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
